An interaction of cis platin and radiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitro
- 1 January 1996
- journal article
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 70 (6) , 747-753
- https://doi.org/10.1080/095530096144635
Abstract
We investigated the interaction of cisplatin and radiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitro. The effects were assessed by clonogenic assay. D0 for the radiosensitivity of the radioresistant variant cell line, NMT-1R was 139 cGy, which was 1.3 times larger than that for the parent radiosensitive cell line, NMT-1 (D0 = 107 cGy). The concentration of cisplatin required to reduce colony formation by 50% at 1 h treatment (ID50 of cisplatin) was 0.25 microgram/ml for NMT-1, whereas that for NMT-1R was 1.0 microgram/ml. Cisplatin potentiation of radiation sensitivity was manifested by the decrease in the slope of the radiation dose-response curve. D0's for NMT-1 and NMT-1R were 83 and 100 cGy in combined treatment with ID50 of cisplatin immediately before radiation. The enhancement ratios of cisplatin were therefore 1.30 for NMT-1 and 1.39 for NMT-1R respectively in D0. No different enhancement ratio for cisplatin was observed in the time course of combination treatment with cisplatin and radiation within the interval of 6 h. There was no clear change in cell cycle distribution within 6 h after treatment with ID50 of cisplatin for both cell lines. In conclusion, cisplatin had a synergistic effect on both cell lines which was independent of the time course and sequence in combination with radiation within 6 h.Keywords
This publication has 15 references indexed in Scilit:
- A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumour cell line, NMT-1: differences of early radiation-induced morphological changes, especially apoptosisInternational Journal of Radiation Biology, 1996
- Induction of cisplatinum sensitivity without alteration in radiation sensitivity by fractionated radiation treatment of a human laryngeal squamous cell carcinoma cell lineInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Cisplatin resistance in mouse fibrosarcoma cells after low-dose irradiation in vitro and in vivoBritish Journal of Cancer, 1994
- Establishment and Characterization of a Rat Yolk Sac Tumor Cell Line, NMT‐1, Producing α‐Fetoprotein, with Potential for Lymphatic MetastasisJapanese Journal of Cancer Research, 1993
- Interactions between antitumour agents and radiation and the expression of resistanceCancer Treatment Reviews, 1991
- Multiple fractions of gamma rays induced resistance to cis-dichloro-diammineplatinum (II) and methotrexate in human HeLa cellsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical dataInternational Journal of Radiation Oncology*Biology*Physics, 1987
- The effects of cis-diamminedichloroplatinum (II) and radiation on the proliferation kinetics of mouse duodenal crypt cells and on a partially synchronized crypt cell populationInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Platinum based combined modality approach for locally advanced head and neck carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1985
- The effect of treatment in fractionated schedules with the combination of x-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skinInternational Journal of Radiation Oncology*Biology*Physics, 1985